Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Neuroone Medical Technologies (NMTC) over the last 10 years, with Q4 2025 value amounting to $1.3 million.

  • Neuroone Medical Technologies' Cost of Revenue fell 166.79% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.9 million, marking a year-over-year increase of 3072.28%. This contributed to the annual value of $4.0 million for FY2025, which is 6669.73% up from last year.
  • Neuroone Medical Technologies' Cost of Revenue amounted to $1.3 million in Q4 2025, which was down 166.79% from $1.2 million recorded in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Cost of Revenue peaked at $1.3 million during Q4 2024, and registered a low of $38462.0 during Q2 2022.
  • In the last 5 years, Neuroone Medical Technologies' Cost of Revenue had a median value of $410456.5 in 2023 and averaged $477954.0.
  • In the last 5 years, Neuroone Medical Technologies' Cost of Revenue skyrocketed by 90421.19% in 2023 and then tumbled by 7605.98% in 2024.
  • Neuroone Medical Technologies' Cost of Revenue (Quarter) stood at $46844.0 in 2021, then surged by 170.87% to $126886.0 in 2022, then surged by 460.61% to $711335.0 in 2023, then soared by 89.4% to $1.3 million in 2024, then decreased by 1.67% to $1.3 million in 2025.
  • Its Cost of Revenue stands at $1.3 million for Q4 2025, versus $1.2 million for Q3 2025 and $781215.0 for Q2 2025.